GSK furthers pharma's greening

GlaxoSmithKline expects to go platinum by 2013 in a plant being built in Philadelphia. That's LEED platinum, the highest rating in the Leadership in Energy & Environmental Design sustainable building rating system. Besides sustainability, design parameters for the four-story, 205,000-square-foot facility are based on the property developer "imagining with GSK how their people will work in the future." GSK release

Suggested Articles

AbbVie will soon own Allergan’s prized Botox franchise, and along with its roughly $4 billion in sales, it will get a new $176 million plant.

Merck KGaA has big plans for a site in Switzerland where it intends to knit together biologics development and manufacturing. 

The FDA has found some issues with Biocon’s small molecule plant in Bengaluru, India.